THU, 29 OCT 2026|
[BRAND]
LATEST
012026 playoff MVP tracker: This year's Mr. October is ...0217 teams that can win 30 games03Qatar denies interference in Israeli elections04Bid-rigging in renovation projects to be criminalised, offenders can be jailed05Fact check: Viral video of JUI-F chief asking for forgiveness in NA is doctored06Israel piles pressure on Arab parties as Netanyahu seeks government07'Painful' years head, think tanks warn, as living standards set to fall08Third-quarter U.S. GDP increases a better-than-expected 3.4% as September inflation accelerates
Feed/Economy · Finance
Economy · Finance

Eli Lilly blows past estimates, hikes sales outlook as Zepbound and Mounjaro demand surge again

CNBC · World
Published 29 Oct 2026, 10:44 pm·1 h ago·1 min read
Listen to this story
Read aloud by your device

Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.

Read the full story at CNBC · World
cnbc.com
Open ↗

Related

Economy · Finance

China slams EU’s potential new trade safeguards, says they may violate WTO rules

17 min ago·South China Morning Post·1 min read
Economy · Finance

China’s BYD, Geely report profit jump as sales abroad surge, though local market stalls

24 min ago·South China Morning Post·1 min read
Economy · Finance

Third-quarter U.S. GDP increases a better-than-expected 3.4% as September inflation accelerates

28 min ago·CNBC · World·1 min read
Economy · Finance

London event advertises Israeli agency building illegal settlements

33 min ago·Middle East Eye·1 min read
Economy · Finance

The Bottom Line

35 min ago·BBC News · Business·1 min read